These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 12811114)
1. Managing healthcare costs within an integrated framework. Fernandes R Healthc Pap; 2002; 3(1):70-6; discussion 87-94. PubMed ID: 12811114 [TBL] [Abstract][Full Text] [Related]
2. Getting the cat back in the bag: reforming the way provinces manage drug expenditures to make them manageable. Levy AR; Gagnon YM Healthc Pap; 2002; 3(1):32-7; discussion 87-94. PubMed ID: 12811108 [TBL] [Abstract][Full Text] [Related]
3. Look beyond budgets to the broader benefits. Dugal R; Mani A; Potvin K Healthc Pap; 2002; 3(1):77-82; discussion 87-94. PubMed ID: 12811115 [TBL] [Abstract][Full Text] [Related]
4. Our advice? Get a budget! Brougham M; Metcalfe S; McNee W Healthc Pap; 2002; 3(1):83-5; discussion 87-94. PubMed ID: 12811116 [TBL] [Abstract][Full Text] [Related]
5. More of the same is not enough. Willison DJ Healthc Pap; 2002; 3(1):47-55; discussion 87-94. PubMed ID: 12811111 [TBL] [Abstract][Full Text] [Related]
6. Drug policy: the challenge is to overcome fragmentation. McFarlance A Healthc Pap; 2002; 3(1):38-42: discussion 87-94. PubMed ID: 12811109 [TBL] [Abstract][Full Text] [Related]
8. Drug policy: making effective drugs available without bankrupting the healthcare system. Laupacis A; Anderson G; O'Brien B Healthc Pap; 2002; 3(1):12-30. PubMed ID: 12811107 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical policies: effects of cap and co-payment on rational drug use. Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125 [TBL] [Abstract][Full Text] [Related]
11. Drug spending in Canada: recent trends and causes. Morgan S Med Care; 2004 Jul; 42(7):635-42. PubMed ID: 15213487 [TBL] [Abstract][Full Text] [Related]
12. The value of medicines in Canada. Han D; Wang EC Can J Clin Pharmacol; 2005; 12(1):e10-21. PubMed ID: 16055940 [TBL] [Abstract][Full Text] [Related]
13. European healthcare policies for controlling drug expenditure. Ess SM; Schneeweiss S; Szucs TD Pharmacoeconomics; 2003; 21(2):89-103. PubMed ID: 12515571 [TBL] [Abstract][Full Text] [Related]
14. Healthcare costs and obesity prevention: drug costs and other sector-specific consequences. Rappange DR; Brouwer WB; Hoogenveen RT; Van Baal PH Pharmacoeconomics; 2009; 27(12):1031-44. PubMed ID: 19908927 [TBL] [Abstract][Full Text] [Related]
15. Finding Truth in a World Full of Spin: Myth-Busting in the Case of Sovaldi. Schiff L Clin Ther; 2015 May; 37(5):1092-112. PubMed ID: 25850880 [TBL] [Abstract][Full Text] [Related]
16. Sustainable health care for Canada. Maxwell J; Angus D; Albert T Leadersh Health Serv; 1995; 4(1):27-31. PubMed ID: 10140965 [TBL] [Abstract][Full Text] [Related]
17. Avoiding fundamental reform: current cost containment strategies in Canada. Manga P J Health Hum Serv Adm; 1998; 20(4):468-501. PubMed ID: 10338722 [TBL] [Abstract][Full Text] [Related]
18. Do drugs reduce utilisation of other healthcare resources? Crémieux PY; Ouellette P; Petit P Pharmacoeconomics; 2007; 25(3):209-21. PubMed ID: 17335307 [TBL] [Abstract][Full Text] [Related]
19. Effective healthcare cost-containment policies: A systematic review. Stadhouders N; Kruse F; Tanke M; Koolman X; Jeurissen P Health Policy; 2019 Jan; 123(1):71-79. PubMed ID: 30429060 [TBL] [Abstract][Full Text] [Related]